New Study Outlines New Ways to Treat Anthrax Infection


Advertisement
by Thilaka Ravi on  May 20, 2010 at 9:16 AM Research News
  •   Print
  •   Share
  •   Comments
  •  Text 
 New Study Outlines New Ways to Treat Anthrax Infection
According to a new study, anthrax-causing bacteria can be engineered to shed their invisibility cloaks, making it easier for the immune system to eradicate it.

The study has been published in Microbiology.

The work could lead to new measures to treat anthrax infection in the event of a biological warfare attack.

Bacillus anthracis is a particularly lethal pathogen because it manages to escape recognition by the host's immune system by coating itself with a protective capsule around its surface. A key bacterial enzyme called capsule depolymerase (CapD) anchors the capsule to the cell surface. CapD can also cut and release some of the capsule into small fragments that are thought to interfere with specific parts of the immune system, offering further protection to the bacterium.

Scientists at the U.S. Army Medical Research Institute of Infectious Diseases discovered that by engineering B. anthracis to produce higher-than-normal amounts of CapD, the protective capsule is chopped up and released as tiny fragments. The bacterium is left nearly completely unmasked and therefore vulnerable to immediate detection and destruction by the macrophage and neutrophil cells of the immune system.

"By engineering B. anthracis to over-produce CapD, we are effectively turning the bacterium's own weapon on itself," explained Dr. Arthur Friedlander, one of the principal investigators in the study.

B. anthracis is the most commonly mentioned pathogen associated with biological warfare. This bacterium can form resilient spores that survive dormant in the environment for long periods of time. When these spores are aerosolised the bacterium can be very effectively distributed. After human inhalation the spores reactivate and cause severe infection that is usually fatal if left untreated.

Dr Friedlander believes his groups' findings could have significant clinical impact.

"Many pathogenic bacteria, including B. anthracis, produce a capsule surrounding them that prevents the infected host from killing them, improving their chances of causing disease," he xplained. "Understanding the mechanisms of virulence used by the anthrax bacterium is vital to developing medical countermeasures against it in the event of a biological attack."

Source-ANI
THK
Do you like this Report?
0

 Email Email  RSS Feeds RSS Feeds  Print this page Print  Save this page Save  Link Link  Syndicate Syndicate  Comments Comments 
 
More News on: Anthrax, Bioterrorism, Flu
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Related Links

Research Related News

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Anthrax
Complete Medindia Resources
News Categories:  
Teen's Health Center